FOSAMAX LINKED TO SERIOUS BONE DISORDER

Recent reports have linked Fosamax to a serious bone disorder known as osteonecrosis of the jaw. For individuals with this disorder, the jaw bone dies and disintegrates due to insufficient blood supply.

Background:

Fosamax, an osteoporosis drug manufactured by Merck, is in a class of drugs called bisphosphonates. It is primarily used to prevent bone loss or the decrease of bone density and is commonly used by post-menopausal women. Recent reports have indicated that individuals taking Fosamax and other bisphosphonates have developed a severe problem where their jaw bone dies from the development of osteonecrosis of the jaw, or ONJ, a rare but serious disorder where the jaw bone dies and disintegrates due to insufficient blood supply.

Individuals who have stopped taking Fosamax may still be at risk. Bisphosphonates remain in the bone for many years, and doctors are unsure of how long the ONJ risk remains. Symptoms of osteonecrosis of the jaw include, facial discomfort or numbness, gum swelling, drainage, poor gum healing, and in some cases individuals may encounter tooth loss.

What you can do:

If you have experienced serious side effects associated with your use of Fosamax and other bisphosphonates, you are urged to see your doctor. It may also be important to contact an attorney who can help you protect your potential legal claim. If you would like more information, or would just like to talk with a lawyer experienced in this litigation, please call attorney Ron Goldser at 1.800.755.0098 for a free consultation or click here to fill out an online free case review.